Secondary Logo

Journal Logo

Articles by Margaret Johnson

Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations

Wong, Alexander; Goldstein, Deborah; Mallolas, Josep; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 82(4):e47-e49, December 1, 2019.

Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial

Johnson, Margaret; Kumar, Princy; Molina, Jean-Michel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(4):463-472, August 1, 2019.

Minimal Cognitive Impairment in UK HIV-Positive Men Who Have Sex With Men: Effect of Case Definitions and Comparison With the General Population and HIV-Negative Men

McDonnell, Jeffrey; Haddow, Lewis; Daskalopoulou, Marina; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(2):120-127, October 1st, 2014.

End-Stage Kidney Disease and Kidney Transplantation in HIV-Positive Patients: An Observational Cohort Study

Gathogo, Esther; Jose, Sophie; Jones, Rachael; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(2):177-180, October 1st, 2014.

Biomarkers to Monitor Safety in People on ART and Risk of Mortality

Bansi, Loveleen; Gazzard, Brian; Post, Frank; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 60(1):51-58, May 1st, 2012.

Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

Mocroft, Amanda; Reiss, Peter; Gasiorowski, Jacek; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(2):262-270, October 1st, 2010.

Low-Frequency K103N Strengthens the Impact of Transmitted Drug Resistance on Virologic Responses to First-Line Efavirenz or Nevirapine-Based Highly Active Antiretroviral Therapy

Geretti, Anna Maria; Fox, Zoe V; Booth, Clare L; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 52(5):569-573, December 2009.

Is 1 Alanine Transaminase >200 IU Enough to Define an Alanine Transaminase Flare in HIV-Infected Populations? A New Definition Derived From a Large Cohort Study

Bansi, Loveleen; Turner, Jo; Gilson, Richard; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 52(3):391-396, November 2009.

Pharmacokinetics, Safety, and Efficacy of Tipranavir Boosted With Ritonavir Alone or in Combination With Other Boosted Protease Inhibitors as Part of Optimized Combination Antiretroviral Therapy in Highly Treatment-Experienced Patients (BI Study 1182.51)

Walmsley, Sharon L; Katlama, Christine; Lazzarin, Adriano; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(4):429-440, April 1st, 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1st, 2008.

The SPICE Study: 48-Week Activity of Combinations of Saquinavir Soft Gelatin and Nelfinavir With and Without Nucleoside Analogues

Moyle, Graeme; Pozniak, Anton; Opravil, Milos; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(2):128-137, February 1st, 2000.

Randomized, Controlled Study of the Safety and Efficacy of Intravenous Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS

Lalezari, Jacob P.; Holland, Gary N.; Kramer, Françoise; More

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 17(4):339-344, April 1st, 1998.